LLY

988.89

+4.36%↑

JNJ

221.79

+0.3%↑

ABBV

203.72

+1.28%↑

NVS

146

+0.05%↑

MRK

112.87

+1.47%↑

LLY

988.89

+4.36%↑

JNJ

221.79

+0.3%↑

ABBV

203.72

+1.28%↑

NVS

146

+0.05%↑

MRK

112.87

+1.47%↑

LLY

988.89

+4.36%↑

JNJ

221.79

+0.3%↑

ABBV

203.72

+1.28%↑

NVS

146

+0.05%↑

MRK

112.87

+1.47%↑

LLY

988.89

+4.36%↑

JNJ

221.79

+0.3%↑

ABBV

203.72

+1.28%↑

NVS

146

+0.05%↑

MRK

112.87

+1.47%↑

LLY

988.89

+4.36%↑

JNJ

221.79

+0.3%↑

ABBV

203.72

+1.28%↑

NVS

146

+0.05%↑

MRK

112.87

+1.47%↑

Home・Elenco Azioni・Exact Sciences Corp

Exact Sciences Corp

Aperta

SettoreSettore sanitario

104.93

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

104.9

Massimo

104.96

Metriche Chiave
By Trading Economics
Entrata	-66M -86M
Vendite	28M 878M
EPS	-0.21
Margine di Profitto	-9.786
Dipendenti	7,100
EBITDA	-68M -20M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	+0.09% upside

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	404M 20B
Apertura precedente	104.93
Chiusura precedente	104.93

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

45.6 / 54.37 Supporto e resistenza

Exact Sciences Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

26 mar 2026, 23:43 UTC

Discorsi di Mercato

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mar 2026, 23:36 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mar 2026, 23:35 UTC

Acquisizioni, Fusioni, Takeovers

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mar 2026, 23:29 UTC

Utili

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mar 2026, 23:28 UTC

Utili

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mar 2026, 23:28 UTC

Utili

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mar 2026, 23:28 UTC

Utili

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mar 2026, 23:27 UTC

Utili

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mar 2026, 23:27 UTC

Utili

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mar 2026, 23:08 UTC

Discorsi di Mercato

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mar 2026, 23:04 UTC

Acquisizioni, Fusioni, Takeovers

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mar 2026, 23:04 UTC

Acquisizioni, Fusioni, Takeovers

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mar 2026, 23:04 UTC

Acquisizioni, Fusioni, Takeovers

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mar 2026, 23:04 UTC

Acquisizioni, Fusioni, Takeovers

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mar 2026, 23:04 UTC

Acquisizioni, Fusioni, Takeovers

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mar 2026, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mar 2026, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mar 2026, 22:26 UTC

Utili

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mar 2026, 22:26 UTC

Utili

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mar 2026, 22:26 UTC

Utili

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mar 2026, 22:08 UTC

Utili

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mar 2026, 22:08 UTC

Utili

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mar 2026, 22:08 UTC

Utili

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mar 2026, 22:07 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Global Energy Roundup: Market Talk

26 mar 2026, 22:07 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mar 2026, 22:00 UTC

Utili

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mar 2026, 22:00 UTC

Utili

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mar 2026, 22:00 UTC

Utili

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mar 2026, 21:39 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mar 2026, 21:38 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Confronto tra pari

Modifica del prezzo

Exact Sciences Corp Previsione

Obiettivo di Prezzo

By TipRanks

0.09% in crescita

Previsioni per 12 mesi

Media 105 USD 0.09%

Alto 105 USD

Basso 105 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Exact Sciences Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

6 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 6 che hanno fornito valutazioni azionarie a Exact Sciences Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

45.6 / 54.37Supporto e resistenza

Recent bullish events outweigh bearish events.

All events are bearish.

Notizie finanziarie

Chi Siamo Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.